94 related articles for article (PubMed ID: 27644574)
1. Analysis of the Prognostic Factors of Extensive Disease Small-Cell Lung Cancer Patients in Tokushima University Hospital.
Ogino H; Hanibuchi M; Kakiuchi S; Saijo A; Tezuka T; Toyoda Y; Tobiume M; Otsuka K; Sakaguchi S; Goto H; Arisawa K; Nishioka Y
J Med Invest; 2016; 63(3-4):286-93. PubMed ID: 27644574
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for survival in extensive stage small cell lung cancer (ED-SCLC): the importance of smoking history, socioeconomic and marital statuses, and ethnicity.
Ou SH; Ziogas A; Zell JA
J Thorac Oncol; 2009 Jan; 4(1):37-43. PubMed ID: 19096304
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factors affecting the risk of thoracic progression in extensive-stage small cell lung cancer.
Fukui T; Itabashi M; Ishihara M; Hiyoshi Y; Kasajima M; Igawa S; Sasaki J; Masuda N
BMC Cancer; 2016 Mar; 16():197. PubMed ID: 26955807
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and risk of cytotoxic chemotherapy in extensive disease-small cell lung cancer patients with interstitial pneumonia.
Shirasawa M; Fukui T; Kusuhara S; Hiyoshi Y; Nakahara Y; Nishinarita N; Igawa S; Naoki K
BMC Cancer; 2019 Feb; 19(1):163. PubMed ID: 30808322
[TBL] [Abstract][Full Text] [Related]
5. The prognostic factors in the elderly patients with small cell lung cancer: a retrospective analysis from a single cancer institute.
Liu S; Guo H; Kong L; Li H; Zhang Y; Zhu H; Yu J
Int J Clin Exp Pathol; 2015; 8(9):11033-41. PubMed ID: 26617821
[TBL] [Abstract][Full Text] [Related]
6. Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.
Foster NR; Mandrekar SJ; Schild SE; Nelson GD; Rowland KM; Deming RL; Kozelsky TF; Marks RS; Jett JR; Adjei AA
Cancer; 2009 Jun; 115(12):2721-31. PubMed ID: 19402175
[TBL] [Abstract][Full Text] [Related]
7. Baseline quality of life and performance status as prognostic factors in patients with extensive-stage disease small cell lung cancer treated with pemetrexed plus carboplatin vs. etoposide plus carboplatin.
Reck M; Thatcher N; Smit EF; Lorigan P; Szutowicz-Zielinska E; Liepa AM; Winfree KB; Peterson P; Guba SC; Socinski MA
Lung Cancer; 2012 Dec; 78(3):276-81. PubMed ID: 23043970
[TBL] [Abstract][Full Text] [Related]
8. Prognostic significance of body mass index and serum albumin as the indicators of nutritional status in small cell lung cancer.
Tas F; Ozturk A; Erturk K
Postgrad Med; 2024 Mar; 136(2):208-217. PubMed ID: 38456321
[TBL] [Abstract][Full Text] [Related]
9. NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer.
Cui X; Jin T; Wang X; Jin G; Li Z; Lin L
Oncol Rep; 2014 Dec; 32(6):2589-95. PubMed ID: 25231218
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-inducible factor-1α and excision repair cross-complementing 1 in patients with small cell lung cancer who received front-line platinum-based chemotherapy: a retrospective study.
Lee GW; Go SI; Cho YJ; Jeong YY; Kim HC; Duk Lee J; Hwang YS; Ko GH; Lee JH; Kim DC; Yang JW; Oh S; Lee JS
J Thorac Oncol; 2012 Mar; 7(3):528-34. PubMed ID: 22258474
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance of NQO1 polymorphism and expression of p53, SOD2, PARP1 in limited-stage small cell lung cancer.
Kim HC; Song JS; Lee JC; Lee DH; Kim SW; Lee JS; Kim WS; Rho JK; Kim SY; Choi CM
Int J Clin Exp Pathol; 2014; 7(10):6743-51. PubMed ID: 25400754
[TBL] [Abstract][Full Text] [Related]
12. Nomograms Predict Overall Survival for Patients with Small-Cell Lung Cancer Incorporating Pretreatment Peripheral Blood Markers.
Xie D; Marks R; Zhang M; Jiang G; Jatoi A; Garces YI; Mansfield A; Molina J; Yang P
J Thorac Oncol; 2015 Aug; 10(8):1213-20. PubMed ID: 26200277
[TBL] [Abstract][Full Text] [Related]
13. High tumor metabolic activity as measured by fluorodeoxyglucose positron emission tomography is associated with poor prognosis in limited and extensive stage small-cell lung cancer.
Lee YJ; Cho A; Cho BC; Yun M; Kim SK; Chang J; Moon JW; Park IK; Choi HJ; Kim JH
Clin Cancer Res; 2009 Apr; 15(7):2426-32. PubMed ID: 19318478
[TBL] [Abstract][Full Text] [Related]
14. Survival of patients with small cell lung carcinoma in Taiwan.
Kuo YH; Lin ZZ; Yang YY; Shao YY; Shau WY; Kuo RN; Yang JC; Lai MS
Oncology; 2012; 82(1):19-24. PubMed ID: 22269348
[TBL] [Abstract][Full Text] [Related]
15. Hypo- or conventionally fractionated radiotherapy combined with chemotherapy in patients with limited stage small cell lung cancer.
Zhang J; Fan M; Liu D; Zhao KL; Wu KL; Zhao WX; Zhu ZF; Fu XL
Radiat Oncol; 2017 Mar; 12(1):51. PubMed ID: 28283034
[TBL] [Abstract][Full Text] [Related]
16. Is (18)F-FDG-PET/CT prognostic factor for survival in patients with small cell lung cancer? Single center experience.
Inal A; Kucukoner M; Kaplan MA; Urakci Z; Nas N; Guven M; Dostbil Z; Altindag S; Isikdogan A
Rev Port Pneumol; 2013; 19(6):260-5. PubMed ID: 23993406
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Factors and Treatment of Early-stage Small-cell Lung Cancer.
Käsmann L; Bolm L; Janssen S; Rades D
Anticancer Res; 2017 Mar; 37(3):1535-1537. PubMed ID: 28314330
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of pretreatment laboratory parameters in combined small-cell lung cancer.
Wang X; Jiang R; Li K
Cell Biochem Biophys; 2014 Jul; 69(3):633-40. PubMed ID: 24554485
[TBL] [Abstract][Full Text] [Related]
19. The applicability of the proposed IASLC staging revisions to small cell lung cancer (SCLC) with comparison to the current UICC 6th TNM Edition.
Ignatius Ou SH; Zell JA
J Thorac Oncol; 2009 Mar; 4(3):300-10. PubMed ID: 19156001
[TBL] [Abstract][Full Text] [Related]
20. The value of prognostic factors in small cell lung cancer: results from a randomised multicenter study with minimum 5 year follow-up.
Bremnes RM; Sundstrom S; Aasebø U; Kaasa S; Hatlevoll R; Aamdal S;
Lung Cancer; 2003 Mar; 39(3):303-13. PubMed ID: 12609569
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
